Literature DB >> 17122649

Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis.

Jolanda M van Dieren1, Josiane C Wink, Kees J Vissers, Ronald van Marion, Monique M C P Hoogmans, Winand N M Dinjens, W Ruud Schouten, Hans J Tanke, Karoly Szuhai, Ernst J Kuipers, C Janneke van der Woude, Herman van Dekken.   

Abstract

Longstanding ulcerative colitis (UC) is associated with a high risk of developing UC-related colonic adenocarcinoma (UCC). These carcinomas originate from nonadenomatous dysplastic regions referred to as dysplasia associated lesion or mass (DALM). We evaluated chromosomal and microsatellite instability (MSI) in 21 DALM/UCCs. Chromosomal instability was determined by high-resolution array comparative genomic hybridization with a 3500-element BAC-PAC array. MSI was assessed with markers BAT25 and BAT26 and by immunohistochemical analysis of mismatch repair genes. Comparative genomic hybridization revealed frequent losses of array clones (>20% of tumors) at chromosome arms 4p, 5q, and 18q, frequent gains of array clones (>20% of tumors) were found at 1q, 5p, 6p, 7p, 7q, 8p, 8q, 11p, 11q, 12q, 14q, 17q, 19q, 20p, and 20q. The pattern of alterations is dominated by gains on 5p and 20q with loss of 4p, all of which were already present in a patient with carcinoma in situ. Immunohistochemical analysis of mismatch repair genes MLH1, PMS2, MSH2, and MSH6 showed negative immunostaining in 1 neoplasm (5%). MSI of BAT25 and BAT26 was seen in 3 tumors (14%) including the neoplasm with aberrant immunostaining. In conclusion, we constructed a genomic profile of DALM/UCC including several novel genetic alterations. Further, we found a low percentage of MSI. Thus, DALM/UCCs display profound chromosomal instability, but this is not associated with concurrent MSI.

Entities:  

Mesh:

Year:  2006        PMID: 17122649     DOI: 10.1097/01.pdm.0000213470.92925.18

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  14 in total

Review 1.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 2.  Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?

Authors:  Jessica K Dyson; Matthew D Rutter
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

3.  Current management of inflammatory bowel disease and colorectal cancer.

Authors:  Mark C Mattar; Denver Lough; Michael J Pishvaian; Aline Charabaty
Journal:  Gastrointest Cancer Res       Date:  2011-03

4.  Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.

Authors:  Florian Kuehn; Ernst Klar; Anja Bliemeister; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 5.  Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Christos Tsaitas; Anysia Semertzidou; Emmanouil Sinakos
Journal:  World J Hepatol       Date:  2014-04-27

Review 6.  [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].

Authors:  D Hirsch
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

Review 7.  Clonal evolution of colorectal cancer in IBD.

Authors:  Chang-Ho R Choi; Ibrahim Al Bakir; Ailsa L Hart; Trevor A Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-08       Impact factor: 46.802

8.  Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.

Authors:  Bhadravathi Marigowda Shivakumar; Harish Rotti; Thanvanthri Gururajan Vasudevan; Aswath Balakrishnan; Sanjiban Chakrabarty; Ganesh Bhat; Lakshmi Rao; Cannanore Ganesh Pai; Kapaettu Satyamoorthy
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 9.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.

Authors:  Karoline Horisberger; Thomas Ried; Timo Gaiser; Daniela Hirsch; Darawalee Wangsa; Yuelin J Zhu; Yue Hu; Daniel C Edelman; Paul S Meltzer; Kerstin Heselmeyer-Haddad; Claudia Ott; Peter Kienle; Christian Galata
Journal:  Clin Cancer Res       Date:  2018-07-02       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.